Neo-synalar Cream
Pricing Report NDC 43538-940-60

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Neo-synalar (NDC 43538-940-60) is $13.21006 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 31, 2020.

As a a human prescription drug provided by Eurofarma, Inc., this medication is distributed in a 1 TUBE in 1 CARTON / 60 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$13.21006
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 31, 2020
Billable Units
60 GM
Estimated Package Price
$792.60
Data Status
As of Jul 14, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
43538-940-60
Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2016, the NADAC wholesale price for (NDC ) has moved within a range of $8.28493 to $13.21006 per GM. Over this 4 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$8.2849 - $13.2101
Market Volatility
59.45% Variance
Latest Trend
6.60%
Date Unit Price Unit Source Method Rate
Jul 31, 2020 $13.21006 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 31, 2020 $13.21006 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 19, 2019 $12.39206 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 19, 2019 $12.39206 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jun 28, 2019 $11.06444 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jun 28, 2019 $11.06444 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 01, 2019 $10.77355 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 01, 2019 $10.77355 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 31, 2018 $10.30282 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 31, 2018 $10.30282 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 29, 2017 $10.02697 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 29, 2017 $10.02697 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
May 09, 2017 $9.54395 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
May 09, 2017 $9.54395 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 31, 2017 $9.21222 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 31, 2017 $9.21222 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jan 04, 2017 $8.89219 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jan 04, 2017 $8.89219 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 30, 2016 $8.58319 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 30, 2016 $8.58319 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 20, 2016 $8.28493 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 20, 2016 $8.28493 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026